Gastroesophageal Reflux Disease Device Market

Gastroesophageal Reflux Disease Device Market contains market size and forecasts of Gastroesophageal Reflux Disease Device in global, including the following market information:
Global Gastroesophageal Reflux Disease Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gastroesophageal Reflux Disease Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Gastroesophageal Reflux Disease Device companies in 2021 (%)
The global Gastroesophageal Reflux Disease Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Esophagoscopy and Gastroscopy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastroesophageal Reflux Disease Device include Addex Therapeutics, Aros Pharma, AstraZeneca, Eisai, EndoGastric Solutions, KARL STORZ, Medigus, Olympus and PENTAX Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gastroesophageal Reflux Disease Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastroesophageal Reflux Disease Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gastroesophageal Reflux Disease Device Market Segment Percentages, by Type, 2021 (%)
Esophagoscopy and Gastroscopy
Fundoplication Devices
Manometry System
PH Monitoring System
Radio Frequency Ablation Devices
Sphincter Augmentation Devices
Ultrasonic Surgical Endostaplers
Global Gastroesophageal Reflux Disease Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gastroesophageal Reflux Disease Device Market Segment Percentages, by Application, 2021 (%)
Hospital-Based Outpatient Departments (HOPD)
Ambulatory Surgical Centers
Global Gastroesophageal Reflux Disease Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gastroesophageal Reflux Disease Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastroesophageal Reflux Disease Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gastroesophageal Reflux Disease Device revenues share in global market, 2021 (%)
Key companies Gastroesophageal Reflux Disease Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Gastroesophageal Reflux Disease Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Addex Therapeutics
Aros Pharma
AstraZeneca
Eisai
EndoGastric Solutions
KARL STORZ
Medigus
Olympus
PENTAX Medical
Pfizer
Procter & Gamble
Takeda Pharmaceutical